Frontline Treatment With Bendamustine in Combination With Rituximab in Adults Age 65 or Older With Chronic Lymphocytic Leukaemia: A Phase II Study.
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 10 Jan 2012
At a glance
- Drugs Bendamustine (Primary) ; Rituximab
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- 10 Jan 2012 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 10 Oct 2008 New trial record.